Detalhe da pesquisa
1.
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Br J Cancer
; 109(1): 121-30, 2013 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23799855
2.
SEOM clinical guideline for treatment of kidney cancer (2019).
Clin Transl Oncol
; 22(2): 256-269, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31993962
3.
Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.
Br J Cancer
; 99(3): 455-8, 2008 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18665167
4.
Parotid gland metastasis of a breast cancer.
Clin Transl Oncol
; 9(4): 264-5, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17462982
5.
SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
Clin Transl Oncol
; 17(12): 956-61, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26669313
6.
Clinical guideline seom: hereditary colorectal cancer.
Clin Transl Oncol
; 17(12): 962-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26586118
7.
Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment.
Clin Transl Oncol
; 17(2): 167-72, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25100066
8.
Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.
Hum Mutat
; 22(5): 417-8, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14517958
9.
Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer.
Clin Transl Oncol
; 16(9): 814-22, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24532305
10.
Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC).
Clin Transl Oncol
; 16(3): 280-4, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982851
11.
Clinical guideline SEOM: hereditary colorectal cancer
Clin. transl. oncol. (Print)
; 17(12): 962-971, dic. 2015. ilus
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-147434
12.
SEOM clinical guidelines in Hereditary Breast and ovarian cancer
Clin. transl. oncol. (Print)
; 17(12): 956-961, dic. 2015. tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-195301
13.
Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer
Clin. transl. oncol. (Print)
; 16(9): 814-822, sept. 2014.
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-126572
14.
Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment
Clin. transl. oncol. (Print)
; 17(2): 167-172, feb. 2015. tab, ilus
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-132888
15.
Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)
Clin. transl. oncol. (Print)
; 16(3): 280-284, mar. 2014.
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-127735
16.
A multimodality approach to localized rectal cancer.
Ann Oncol
; 17 Suppl 10: x129-34, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17018713
17.
Oncological emergencies.
Ann Oncol
; 15 Suppl 4: iv299-306, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15477325
18.
Impact of a mammography screening programme on the breast cancer population of the Region of Valencia (Spain)
Clin. transl. oncol. (Print)
; 10(11): 745-752, nov. 2008. tab, ilus
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-123549
19.
Parotid gland metastasis of a breast cancer
Clin. transl. oncol. (Print)
; 9(4): 264-265, abr. 2007. ilus
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-123304
20.
Trastuzumab en el tratamiento del cáncer de mama con amplificación de HER2 / Trastuzumab therapy in HER-2 overexpressing breast cancer
Rev. senol. patol. mamar. (Ed. impr.)
; 19(1): 4-12, ene.-mar. 2006. ilus
Artigo
em Es
| IBECS (Espanha) | ID: ibc-047839